BCT — Briacell Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Briacell Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	2019 July 31st	2020 July 31st	C2021 July 31st	2022 July 31st	2023 July 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	fx Final	fx Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.146	0.019	57.3	41	21.3
Net Total Accounts Receivable
Net Total Receivables	0.003	0.021	0.013	0.024	0.019
Prepaid Expenses
Total Current Assets	0.157	0.239	57.8	42.3	26.9
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.414	0.478	58	42.6	27.2
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.755	3.63	0.557	0.941	1.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.06	3.77	30.4	32.2	30.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.642	-3.3	27.7	10.3	-3.78
Total Liabilities & Shareholders' Equity	0.414	0.478	58	42.6	27.2
Total Common Shares Outstanding